Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

616 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Relapsing Malaria: A Case Report of Primaquine Resistance.
Dijanic C, Nickerson J, Shakya S, Dijanic A, Fabbri M. Dijanic C, et al. Among authors: fabbri m. Case Rep Infect Dis. 2018 Mar 11;2018:9720823. doi: 10.1155/2018/9720823. eCollection 2018. Case Rep Infect Dis. 2018. PMID: 29713556 Free PMC article.
Tocilizumab for Severe and Critical COVID-19 Pneumonia in Queens, NYC.
Salama C, Kaplan-Lewis E, Durrance R, Wong L, Arumugam V, Fabbri M. Salama C, et al. Among authors: fabbri m. Infect Dis Clin Pract (Baltim Md). 2021 Jul;29(4):e215-e220. doi: 10.1097/IPC.0000000000000988. Epub 2021 Jan 15. Infect Dis Clin Pract (Baltim Md). 2021. PMID: 34276173 Free PMC article.
Primary Tuberculous Pyomyositis of the Calf Muscles.
Al-Khazraji A, Takher J, Alkhawam H, Fabbri M. Al-Khazraji A, et al. Among authors: fabbri m. Am J Med Sci. 2017 Feb;353(2):187-188. doi: 10.1016/j.amjms.2016.05.010. Epub 2016 May 19. Am J Med Sci. 2017. PMID: 28183421 No abstract available.
Hantavirus Pulmonary Syndrome in the United States.
Fabbri M, Maslow MJ. Fabbri M, et al. Curr Infect Dis Rep. 2001 Jun;3(3):258-265. doi: 10.1007/s11908-001-0028-1. Curr Infect Dis Rep. 2001. PMID: 11384556 Free PMC article.
Trial of Lixisenatide in Early Parkinson's Disease.
Meissner WG, Remy P, Giordana C, Maltête D, Derkinderen P, Houéto JL, Anheim M, Benatru I, Boraud T, Brefel-Courbon C, Carrière N, Catala H, Colin O, Corvol JC, Damier P, Dellapina E, Devos D, Drapier S, Fabbri M, Ferrier V, Foubert-Samier A, Frismand-Kryloff S, Georget A, Germain C, Grimaldi S, Hardy C, Hopes L, Krystkowiak P, Laurens B, Lefaucheur R, Mariani LL, Marques A, Marse C, Ory-Magne F, Rigalleau V, Salhi H, Saubion A, Stott SRW, Thalamas C, Thiriez C, Tir M, Wyse RK, Benard A, Rascol O; LIXIPARK Study Group. Meissner WG, et al. Among authors: fabbri m. N Engl J Med. 2024 Apr 4;390(13):1176-1185. doi: 10.1056/NEJMoa2312323. N Engl J Med. 2024. PMID: 38598572 Clinical Trial.
Amantadine use in the French prospective NS-Park cohort.
Fabbri M, Rousseau V, Corvol JC, Sommet A, Tubach F, De Rycke Y, Bertille N, Selvarasa Y, Carvalho S, Chaigneau V, Brefel-Courbon C, Ory-Magne F, Tessier S, Tir M, Bereau M, Meissner WG, Thiriez C, Marques A, Remy P, Schneider V, Moro E, Defebvre L, Houeto JL, Prange S, Eusebio A, Geny C, Frismand S, Damier P, Reuther CG, Castelnovo G, Benatru I, De Maindreville AD, Drapier S, Maltête D, Lagha-Boukbiza O, Rascol O; French N. S.-Park network. Fabbri M, et al. J Neural Transm (Vienna). 2024 Apr 5. doi: 10.1007/s00702-024-02772-4. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 38578434
616 results